Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Not Excluding The Pharmaceutical Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Ws Ranibizumab (atc Code According To Who 2026-05-31
Tunisia Acquisition Of Reagents With The Installation Of An Automated System For The Immunology Laboratory 2026-06-01
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Paragraph 8 Sgb V With The Active Ingredient Filgrastim. 2026-06-01
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Filgrastim. 2026-06-01
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-01
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-01
Finland Procurement Of Somatic Specialized Medical Care 2026-06-01
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Teriparatide 2026-06-01
Germany Open House Discount Contracts 202515 2026-06-01
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Insulin Lispro, Atc A10ab04 And A10ad04 For The Period 01.01.2026 To 31.12.2027 2026-06-01
Whats app